Neuroservices-Alliance
Bruno Buisson has an extensive work experience in the field of neuroscience and pharmacology. Bruno is currently the Founder, President, and CSO at Neuroservices Alliance, a position they have held since March 2019. Prior to this, Bruno was the General Manager & Chief Scientist at NEUROSERVICE from July 2006.
Bruno'sprevious role at TROPHOS SA as the Head of Dpt Pharmacology involved the selection and investigation of lead compounds, as well as the characterization of their targets and mechanisms of action. Bruno also designed and performed in vitro pharmacological assays for lead compound development. Bruno worked at TROPHOS SA from November 2000 to June 2006.
Bruno's early career involved academic research and teaching at the University of Geneva. Bruno served as a Master Assistant from September 1996 to November 2000, where they conducted Patch-Clamp recordings to characterize the properties of human nicotinic receptors. Bruno also taught medical students during this time. Prior to that, they worked as a Post-Doc and Master Assistant at the Department of Physiology from January 1993 to August 1996.
Bruno Buisson completed their Master's degree in Biochemistry/Neuroscience from Ecole Normale Supérieure de Cachan between 1986 and 1990. Later, they pursued their PhD in Neuroscience from the University of Montpellier from 1990 to 1993.
This person is not in any teams
This person is not in any offices
Neuroservices-Alliance
Neuroservices-Alliance: The CNS Electrophysiology CRO. . Our mission Neuroservices-Alliance is a Global CNS Contract Research Organization (CRO) for translational data. We are committed to provide the Pharmaceutical Industry with state-of-the-art neuro-pharmacological functional endpoints, helping them accelerate their CNS and Pain drug discovery programs. . Our expertise Empowered by a strong college of experts, our integrated functional data from Rodent, Dog, Cyno and Human tissues accelerate CNS and Pain research programs thanks to fast and robust lead selection & optimization, investigation of MOA, and validation of target engagement. Data are generated from complementary CNS platforms: in vitro & in vivo CNS electrophysiology and behavioral tests. . Our core values We are the alliance of Human and Science. We value direct and efficient interactions and act as our clients’ remote laboratory: you remain in constant contact with our scientific team all along the study, while having the support of our business & operations team for all contractual and project management matters. Our study plans remain flexible to be quickly adapted to the ongoing projects needs.